Coagulation disorders after reperfusion of pancreatic allografts.
Nader
A
A
Department of Surgery, University of Tübingen, Germany.
Büsing
M
M
Blumenstock
I
I
Heimburger
N
N
Jochum
M
M
Hopt
U T
UT
D000925:Anticoagulants / Q000627:therapeutic use; D000990:Antithrombin III / Q000627:therapeutic use; D001778:Blood Coagulation Disorders / Q000097:blood / Q000209:etiology* / Q000517:prevention & control; D004386:Duodenum / Q000637:transplantation*; D006493:Heparin / Q000627:therapeutic use; D006801:Humans; D007166:Immunosuppressive Agents / Q000627:therapeutic use; D016030:Kidney Transplantation / Q000379:methods / Q000502:physiology*; D016035:Pancreas Transplantation / Q000379:methods / Q000502:physiology*; D011183:Postoperative Complications / Q000097:blood*; D011446:Prospective Studies; D015424:Reperfusion
D000925:Anticoagulants; D007166:Immunosuppressive Agents; D000990:Antithrombin III; D006493:Heparin